Inventor
RICE KENNER C
US43 patents
⚠️ This page may combine multiple inventors who share the name “RICE KENNER C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
25 patentsUS5679673AOct 21, 1997
Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
US HEALTH74 citations96
US4613668ASep 23, 1986
Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
US HEALTH82 citations96
US4521601AJun 4, 1985
Practical total synthesis unnatural enantiomers of opium-derived morphinans
US HEALTH78 citations96
US4727146AFeb 23, 1988
Synthesis of chiral 1-benzyl-1,2,3,4-tetra-hydroisoquinolines by asymmetric reduction
US HEALTH28 citations92
US4410700AOct 18, 1983
Preparation of chiral 1-benzyl-1,2,3,4-tetrahydroisoquinolines by optical resolution
US HEALTH47 citations92
US6395900B1May 28, 2002
Methods of O-demethylation and N-deprotection
US HEALTH23 citations90
US4775759AOct 4, 1988
Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)
US HEALTH46 citations90
US6387389B1May 14, 2002
Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use
US HEALTH25 citations87
US9765031B2Sep 19, 2017
Cannabinoid receptor mediating compounds
US HEALTH10 citations82
US4556712ADec 3, 1985
Preparation and racemization of chiral 1-benzyl-1,2,3,4-tetrahydroisoquinolines
US HEALTH26 citations82
US5958920ASep 28, 1999
Aralkyl diazabicycloalkane derivatives for CNS disorders
US HEALTH9 citations73
US10787419B2Sep 29, 2020
Cannabinoid receptor mediating iminopyrazole compounds
US HEALTH2 citations71
US5208338AMay 4, 1993
Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans
US HEALTH5 citations71
US4598153AJul 1, 1986
Metaphit, a specific acylating agent for the [3 H] phencyclidine
US HEALTH7 citations70
US5856318AJan 5, 1999
Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivatives for CNS disorders
US HEALTH2 citations62
US5679679AOct 21, 1997
Aralkyl diazabicycloalkane derivatives for CNS disorders
US HEALTH6 citations62
US5656625AAug 12, 1997
Nitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disorders
US HEALTH3 citations62
US5346908ASep 13, 1994
Nitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disorders
US HEALTH3 citations62
US10329259B2Jun 25, 2019
Pyrazole derivatives and their use as cannabinoid receptor mediators
US HEALTH1 citations60
US5196415AMar 23, 1993
5-aminocarbonyl-5H-dibenzo[a.d]cyclohepten-5,10-imines for treatment of epilepsy and cocaine addiction
US HEALTH6 citations59
US5008449AApr 16, 1991
Method of synthesis of hydroxy-substituted-4-alkoxyphenylacetic acids
US HEALTH1 citations52
US4139713AFeb 13, 1979
Steroidal intermediates from the condensation product of dimethyl-3-ketoglutarate and glyoxal
US HEALTH0 citations52
US10683270B2Jun 16, 2020
Cannabinoid receptor mediating compounds
US HEALTH0 citations50
US4762846AAug 9, 1988
Metaphit and related compounds as acylating agents for the (3H)phencyclidine receptors
US HEALTH0 citations48
US6656930B2Dec 2, 2003
Aralkyl diazabicycloalkane derivatives for CNS disorders
US HEALTH0 citations40
US ARMY
7 patentsUS5336483AAug 9, 1994
Radiolabeled n-substituted-6-iodo-3,14-dihydroxy-4, 5α-epoxymorphinans, intermediates for producing the same, and a process for the preparation and methods of detecting opioid receptors
US ARMY21 citations90
US6046200AApr 4, 2000
Compositions having neuroprotective and analgesic activity
US ARMY12 citations69
US5571832ANov 5, 1996
Nitrogen-containing cyclohetero alkylamino aryl derivatives for CNS disorders
US ARMY14 citations69
US5739158AApr 14, 1998
Nitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for CNS disorders
US ARMY4 citations59
US6410537B1Jun 25, 2002
Compositions having neuroprotective and analgesic activity
US ARMY2 citations58
US5604255AFeb 18, 1997
N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injury
US ARMY1 citations50
US9193739B2Nov 24, 2015
Induction of highly specific antibodies to a hapten but not to a carrier peptide by immunization
US ARMY1 citations44
SEARLE & CO
2 patentsUS HEALTH EDUCATION & WELFARE
2 patentsUS4150236AApr 17, 1979
Steroidal intermediates from the condensation product of dimethyl-3-ketoglutarate and glyoxal
US HEALTH EDUCATION & WELFARE1 citations63
US4069241AJan 17, 1978
Steroidal intermediates from the condensation product of dimethyl-3-ketoglutarate and glyoxal
US HEALTH EDUCATION & WELFARE0 citations52